ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis (MTX01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00037102
Recruitment Status : Completed
First Posted : May 17, 2002
Last Update Posted : April 12, 2018
Sponsor:
Collaborators:
Consultants in Neurology
Biogen
Information provided by (Responsible Party):
Vernon D. Rowe III, MD, MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2003
  Actual Study Completion Date : December 2003